| 2026-07-24 | baseline | | | baseline | Initial verified baseline: 40 of 48 price points confirmed at official sources by AI web-fetch (screenshots pending Day-2 human pass); 8 rows still collecting | |
| 2026-07-24 | Wegovy pill 4mg / NovoCare | 149 | 199 | announced-increase | NovoCare page states 4mg pill is $149/mo through Aug 31 2026 then rises to $199/mo — lock-in window closes Aug 31 | |
| 2026-07-24 | Wegovy+Ozempic pens intro / NovoCare | | 199 | announced-window | $199 intro price (0.25/0.5mg; 2 monthly fills) runs through Dec 31 2026 | |
| 2026-07-24 | Foundayo savings card | | 25 | announced-window | $25 commercial-insurance card and self-pay offers expire 12/31/2026 | |
| 2026-08-02 | re-verification pass | | | verification | Aug 2 re-verification at source: Foundayo ladder, NovoCare Wegovy pill+pen guide, TrumpRx table and Hims program prices all re-confirmed. No price moved. | |
| 2026-08-02 | Wegovy pill 9mg + 25mg / NovoCare | | 299 | new-row | Titration cliff added to the tracker: the $149 headline covers 1.5mg and 4mg only. 9mg and 25mg are $299/mo - a 2x step most comparisons do not show. | |
| 2026-08-02 | Wegovy pen intro / NovoCare | 199 | 349 | announced-increase | Intro $199 confirmed as 2 monthly fills through Dec 31 2026, then $349/mo for 0.25-2.4mg and $399/mo for HD 7.2mg. Second dated wedge. | |
| 2026-08-02 | Hims Ozempic pen + Mounjaro | | 199 / 1899 | new-row | Hims program coverage completed: Ozempic pen $199/mo; Mounjaro $1,899/mo with no discount program - the contrast row that shows what the programs are worth. | |